A Comparative Study Between the Different Levels of TMJ Arthroscopy in the Management of TMJ Internal Derangement

October 7, 2023 updated by: Mohamed Hamza Fayad, Alexandria University

A Comparative Study Between the Different Levels of TMJ Arthroscopy in the Management of TMJ Internal Derangement (A Randomized Clinical Trial)

The temporomandibular joint (TMJ) arthroscopy has emerging role nowadays in the treatment of TMJ internal derangement with its three levels of intervention. A comparative study between the 3 levels is essential to develop a standardized selection criteria and management algorithm.

Study Overview

Study Type

Interventional

Enrollment (Actual)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt
        • Alexandria University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients with TMJ internal derangement Wilkes III

Exclusion Criteria:

  1. Medically unfit patients.
  2. Patients with TMDs secondary to malocclusion.
  3. Psychological instability.
  4. Patients operated before for other TMJ problems.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: level (I) arthroscopy (Lysis and lavage)
Group I: 10 patients will be treated with Lysis and lavage
Group II: 10 patients will be treated with operative arthroscopy
Group III: 10 patients will be treated with operative arthroscopy + discopexy
Active Comparator: level (II) arthroscopy (operative arthroscopy)
Group I: 10 patients will be treated with Lysis and lavage
Group II: 10 patients will be treated with operative arthroscopy
Group III: 10 patients will be treated with operative arthroscopy + discopexy
Active Comparator: level (III) arthroscopy (operative arthroscopy + disc repositioning and fixation)
Group I: 10 patients will be treated with Lysis and lavage
Group II: 10 patients will be treated with operative arthroscopy
Group III: 10 patients will be treated with operative arthroscopy + discopexy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mouth opening measurement
Time Frame: 1, 3 and 6 months postoperatively
measuring the maximal interincisal opening (MIO)
1, 3 and 6 months postoperatively

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mohamed Fayad, MD, Alexandria University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2021

Primary Completion (Actual)

December 1, 2022

Study Completion (Actual)

July 30, 2023

Study Registration Dates

First Submitted

August 22, 2023

First Submitted That Met QC Criteria

August 22, 2023

First Posted (Actual)

August 28, 2023

Study Record Updates

Last Update Posted (Estimated)

October 10, 2023

Last Update Submitted That Met QC Criteria

October 7, 2023

Last Verified

October 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 001056 - IORG 0008839

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on TMJ Disc Disorder

Clinical Trials on three levels of TMJ arthroscopy

3
Subscribe